Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 80425-0419

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 80425-0419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Dr 20mg #30 (Esomeprazole Magnesium Dr 20mg 80425 0419 01)

Esomeprazole Magnesium Dr 20mg #30 (Esomeprazole Magnesium Dr 20mg 80425 0419 01)
This is a description of an "ESOMEPRAZOLE MAGNESIUM DR 20MG CAPSULE" with a quantity of 30 capsules. The medication is compared to NEXIUM and contains lot number XX00OX with an expiration date of 5/31/2025. The manufacturer is Camber Pharmaceuticals, with serial number 000000253062.*
FDA Label Image

Esomeprazole Magnesium Dr 20mg #60 (Esomeprazole Magnesium Dr 20mg 80425 0419 02)

FDA Label Image

Esomeprazole Magnesium Dr 20mg #90 (Esomeprazole Magnesium Dr 20mg 80425 0419 03)

Esomeprazole Magnesium Dr 20mg #90 (Esomeprazole Magnesium Dr 20mg 80425 0419 03)
This text provides information about a package of Esomeprazole Magnesium DR 20mg capsules, which is a generic version of Nexium. The package contains 90 capsules and has a lot number and expiration date specified. It was packed by a store at a temperature of 20°C (68°F). The manufacturer listed is Camber Pharmaceut*icals.*
FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This is a list of different medications and a placebo in a study, including Esomeprazole Magnesium Delayed-Release Capsules in varying strengths – 40 mg, 20 mg, and 10 mg, as well as a placebo. The number of participants (N) for each treatment group is provided. The study likely evaluates the percentage of participants who maintained a certain condition or response.*
FDA Label Image

Figure-3 (Figure 3)

FDA Label Image

Figure-4 (Figure 4)

FDA Label Image

Figure-5 (Figure 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.